U.S. stock market midday update: GRML down 12.78% on increased volume, no negative news but funds are fleeing?Price Alert·1 hour agoGRML-14.36%
Weekly Recap | Ark Innovation ETF +6.3%, crypto and biotech lead the chargeWeekly Review·2 days ago, 01:16 AMARKK-1.82%
Weekly Recap | Sutro Biopharma +2.73%, consensus target well above spotWeekly Review·2 days ago, 12:44 AMSTRO-2.08%
Weekly Recap | United Therap +2.68%, most brokers rate it buyWeekly Review·2 days ago, 12:44 AMUTHR-0.05%
Weekly Recap | ImmunityBio this week, a quiet, low-volume weekWeekly Review·2 days ago, 12:07 AMIBRX-2.12%
Weekly Recap | CRISPR Therap +11.11%, consensus target above spotWeekly Review·2 days ago, 11:51 PMCRSP-4.02%
Weekly Recap | BioNTech SE +25.22%, mRNA cancer vaccine breakthrough lifts sectorWeekly Review·2 days ago, 11:40 PMBNTX-4.35%
CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 8-K: FY2026 Q2 Revenue: USD 0Earnings Watch·Aug 13 at 07:42 AMCINGW-34.07%
CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 0Earnings Watch·May 14 at 07:12 AMCINGW-34.07%
CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 13, 2025 at 04:23 PMCINGW-34.07%
CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 8-K: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 13, 2025 at 07:17 AMCINGW-34.07%
CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -1.09Earnings Watch·Aug 19, 2025 at 07:58 AMCINGW-34.07%
CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 8-K: FY2025 Q2 EBIT: USD -4.65 MEarnings Watch·Aug 19, 2025 at 07:53 AMCINGW-34.07%
CINGULATE INC C/WTS 10/12/2026 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -1.04Earnings Watch·May 8, 2025 at 03:42 PMCINGW-34.07%
